<DOC>
	<DOCNO>NCT01956110</DOCNO>
	<brief_summary>This trial investigate effect FE 999049 compare Gonal-F .</brief_summary>
	<brief_title>Evidence-based Stimulation Trial With Human rFSH Europe Rest World 1</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Informed Consent Documents sign prior screen evaluation In good physical mental health Premenopausal females age 18 40 year Infertile woman diagnose tubal infertility , unexplained infertility , endometriosis stage I/II partner diagnose male factor infertility , eligible vitro fertilisation ( IVF ) and/or intracytoplasmic sperm injection ( ICSI ) use fresh frozen ejaculate sperm male partner sperm donor Infertility least one year randomisation subject ≤37 year least 6 month subject ≥38 year ( applicable case tubal severe male factor infertility ) The trial cycle subject 's first control ovarian stimulation cycle IVF/ICSI Hysterosalpingography , hysteroscopy , saline infusion sonography , transvaginal ultrasound document uterus consistent expect normal function ( e.g . evidence clinically interfere uterine fibroid define submucous intramural fibroid large 3 cm diameter , polyps congenital structural abnormality associate reduced chance pregnancy ) within 1 year prior randomisation Transvaginal ultrasound document presence adequate visualisation ovary , without evidence significant abnormality ( e.g . endometrioma great 3 cm enlarged ovary would contraindicate use gonadotropin ) normal adnexa ( e.g . hydrosalpinx ) within 1 year prior randomisation . Both ovary must accessible oocyte retrieval . Early follicular phase ( cycle day 24 ) serum level FSH 1 15 IU/L ( result obtain within 3 month prior randomisation ) Body mass index ( BMI ) 17.5 32.0 kg/m2 ( inclusive ) screen Known endometriosis stage IIIIV One follicles ≥10 mm observe transvaginal ultrasound prior randomisation stimulation day 1 Known history recurrent miscarriage ( define three consecutive loss ultrasound confirmation pregnancy ( excl . ectopic pregnancy ) week 24 pregnancy ) Known abnormal karyotype subject partner/sperm donor , applicable , depend source sperm use insemination trial . Any know clinically significant systemic disease ( e.g . insulindependent diabetes ) Any know endocrine metabolic abnormality ( pituitary , adrenal , pancreas , liver kidney ) compromise participation trial exception control thyroid function disease Known tumours ovary , breast , uterus , adrenal gland , pituitary hypothalamus would contraindicate use gonadotropin .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>